Evidence map›Paper›PMID 42582765›Full record

ArticleClinical & translational immunology2026

Sustained response to rituximab in an ANCA-negative necrotizing vasculitis with initial detection of

Nadine Al-Azem, Anna Knothe, Jan-Dirk Raguse, Inga Nierkamp, Achim Georg Beule, Claudia Rudack, Friedericke Müller, Anne Kerlikowki, Eva Wardelmann, Hermann Pavenstädt and 2 more

Abstract read
In one paragraph

Article in Clinical & translational immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nadine Al-AzemSection of Rheumatology and Clinical Immunology, Department of Medicine D University Hospital Münster Münster Germany.
Anna KnotheSection of Rheumatology and Clinical Immunology, Department of Medicine D University Hospital Münster Münster Germany.
Jan-Dirk RaguseDepartment of Oral and Maxillofacial Surgery Fachklinik Hornheide Münster Germany.
Inga NierkampClinic for Ear, Nose, and Throat Disorders University Hospital Münster Münster Germany.
Achim Georg BeuleClinic for Ear, Nose, and Throat Disorders University Hospital Münster Münster Germany.ORCID https://orcid.org/0000-0002-1622-6077
Claudia RudackClinic for Ear, Nose, and Throat Disorders University Hospital Münster Münster Germany.
Friedericke MüllerGerhard-Domagk-Institute of Pathology University Hospital Münster Münster Germany.
Anne KerlikowkiGerhard-Domagk-Institute of Pathology University Hospital Münster Münster Germany.
Eva WardelmannGerhard-Domagk-Institute of Pathology University Hospital Münster Münster Germany.
Hermann PavenstädtSection of Rheumatology and Clinical Immunology, Department of Medicine D University Hospital Münster Münster Germany.
Martin A KriegelSection of Rheumatology and Clinical Immunology, Department of Medicine D University Hospital Münster Münster Germany.
Rebecca HasseliSection of Rheumatology and Clinical Immunology, Department of Medicine D University Hospital Münster Münster Germany.ORCID https://orcid.org/0000-0002-2982-8253

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: In this case, we present a patient with rapidly progressive unilateral destructive orbital and midface inflammation. Initial detection of Methods: A 79-year-old woman presented with acute left periorbital pain, tearing and purulent discharge. The workup included serial microbiological cultures, fungal and mycobacterial testing, molecular diagnostics, CT/MRI/PET-CT imaging, multiple surgical biopsies with histopathology and special stains, ANCA testing, and multidisciplinary treatments (antimicrobials, glucocorticoids, methotrexate and rituximab). The clinical course, laboratory work, imaging studies, histological analysis and response to treatment were thoroughly reviewed. Results: Initial conjunctival culture revealed Conclusion: This case illustrates a rare, localised ANCA-negative necrotizing small-vessel vasculitis with destructive orbital involvement and initial detection of

Indexed as

B cell depletioninfectious diseaseinflammatory diseaseorbital destruction

Identifiers

PMID42582765
PMCPMC13458720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.